SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-009331
Filing Date
2023-03-23
Accepted
2023-03-23 08:16:01
Documents
81
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mgta-20221231.htm   iXBRL 10-K 3254240
2 EX-4.3 mgta-ex4_3.htm EX-4 47540
3 EX-10.10 mgta-ex10_10.htm EX-10 156747
4 EX-10.11 mgta-ex10_11.htm EX-10 157224
5 EX-21.1 mgta-ex21_1.htm EX-21 5346
6 EX-23.1 mgta-ex23_1.htm EX-23 5598
7 EX-31.1 mgta-ex31_1.htm EX-31 15527
8 EX-32.1 mgta-ex32_1.htm EX-32 12178
9 GRAPHIC img185564099_0.jpg GRAPHIC 143146
10 GRAPHIC img185564099_1.jpg GRAPHIC 132591
11 GRAPHIC img185564099_2.jpg GRAPHIC 220284
12 GRAPHIC img185564099_3.jpg GRAPHIC 92370
  Complete submission text file 0000950170-23-009331.txt   12826107

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgta-20221231_lab.xml EX-101.LAB 491966
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgta-20221231_def.xml EX-101.DEF 345537
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgta-20221231_pre.xml EX-101.PRE 421846
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgta-20221231_cal.xml EX-101.CAL 53540
17 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgta-20221231.xsd EX-101.SCH 50420
75 EXTRACTED XBRL INSTANCE DOCUMENT mgta-20221231_htm.xml XML 2009667
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38541 | Film No.: 23754544
SIC: 2834 Pharmaceutical Preparations